normative

Insulin Makers Won't Buy CGMs; Value Follows Data

Insulin manufacturers are not interested in buying CGM makers because they are pharmaceutical businesses, and Dexcom is staying in its lane because value accrues to whoever captures patient glucose data first.

normativepending

Speaker

Aneal

Evidence Quote

“I think they realize that the value actually accrues to the party that gets the patient data.”

Source

Dexcom: Digitizing Diabetes Management— Business Breakdowns
Created: 11/20/2026, 5:18:27 AM

Your notes

Loading notes...